ENTITY
SK Biopharmaceuticals

SK Biopharmaceuticals (326030 KS)

121
Analysis
Health CareSouth Korea
SK Biopharmaceuticals Co., Ltd. researches and develops new drugs. The Company develops and markets brain disorders treatment drugs, central nervous system disorders treatment drugs, and other products. SK Biopharmaceuticals markets its products worldwide.
more
Refresh
bullishKrafton
14 Dec 2020 09:14

2021 Major IPOs Pipeline in Korea

This is our 6th "Annual Edition of the Major Korean IPOs Pipeline Preview" already at Smartkarma! In this report, we have identified 50 companies...

Logo
557 Views
Share
26 Oct 2020 09:29

KOSPI200 Index Rebalance Preview: Review Period Nearly Complete, Nine (Or Ten) Possible Changes

The KOSPI200 index review will be announced in the next 4 weeks. We see 9 inclusions/ exclusions and significant volume to sell on the deletions....

Logo
393 Views
Share
23 Oct 2020 13:14

Will SK Holdings Required to Sell a 25% Stake in SK Biopharm Due to Changes in the Fair Trade Act?

One of the most important developments arising in Korea is the potential amendment of the Fair Trade Act, which includes taking strict actions...

Logo
345 Views
Share
bullishHYBE
16 Sep 2020 10:53
Logo
325 Views
Share
bullishKakao Games
10 Sep 2020 06:08
Logo
337 Views
Share
x